Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment.
Haoyu WuJian'an LuanVincenzo ForgettaJames C EngertGeorge ThanassoulisVincent MooserNicholas J WarehamClaudia LangenbergJohn Brent RichardsPublished in: Circulation. Genomic and precision medicine (2021)
A substantial proportion of suggested testing for elevated Lp(a) and a modest proportion of testing for elevated ApoB could potentially be reduced by prescreening individuals with PRSs.
Keyphrases